Controlled tumor heterogeneity in a co-culture system by 3D bio-printed tumor-on-chip model.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
22 08 2023
22 08 2023
Historique:
received:
16
05
2023
accepted:
16
08
2023
medline:
24
8
2023
pubmed:
23
8
2023
entrez:
22
8
2023
Statut:
epublish
Résumé
Cancer treatment resistance is a caused by presence of various types of cells and heterogeneity within the tumor. Tumor cell-cell and cell-microenvironment interactions play a significant role in the tumor progression and invasion, which have important implications for diagnosis, and resistance to chemotherapy. In this study, we develop 3D bioprinted in vitro models of the breast cancer tumor microenvironment made of co-cultured cells distributed in a hydrogel matrix with controlled architecture to model tumor heterogeneity. We hypothesize that the tumor could be represented by a cancer cell-laden co-culture hydrogel construct, whereas its microenvironment can be modeled in a microfluidic chip capable of producing a chemical gradient. Breast cancer cells (MCF7 and MDA-MB-231) and non-tumorigenic mammary epithelial cells (MCF10A) were embedded in the alginate-gelatine hydrogels and printed using a multi-cartridge extrusion bioprinter. Our approach allows for precise control over position and arrangements of cells in a co-culture system, enabling the design of various tumor architectures. We created samples with two different types of cells at specific initial locations, where the density of each cell type was carefully controlled. The cells were either randomly mixed or positioned in sequential layers to create cellular heterogeneity. To study cell migration toward chemoattractant, we developed a chemical microenvironment in a chamber with a gradual chemical gradient. As a proof of concept, we studied different migration patterns of MDA-MB-231 cells toward the epithelial growth factor gradient in presence of MCF10A cells in different ratios using this device. Our approach involves the integration of 3D bioprinting and microfluidic devices to create diverse tumor architectures that are representative of those found in various patients. This provides an excellent tool for studying the behavior of cancer cells with high spatial and temporal resolution.
Identifiants
pubmed: 37607994
doi: 10.1038/s41598-023-40680-x
pii: 10.1038/s41598-023-40680-x
pmc: PMC10444838
doi:
Substances chimiques
Hydrogels
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
13648Subventions
Organisme : CIHR
Pays : Canada
Informations de copyright
© 2023. Springer Nature Limited.
Références
Blood. 2013 May 23;121(21):e129-37
pubmed: 23471306
Sci Rep. 2019 Dec 27;9(1):19914
pubmed: 31882581
Biotechnol J. 2009 Aug;4(8):1168-77
pubmed: 19507149
Biofabrication. 2010 Sep;2(3):035003
pubmed: 20823504
Biomaterials. 2016 Nov;106:58-68
pubmed: 27552316
Biofabrication. 2018 Jun 29;10(3):034106
pubmed: 29923501
J Control Release. 2021 May 10;333:91-106
pubmed: 33774120
Nat Mater. 2012 Sep;11(9):768-74
pubmed: 22751181
Polymers (Basel). 2020 Oct 24;12(11):
pubmed: 33114344
Adv Mater. 2022 Jan;34(2):e2103691
pubmed: 34672027
J Mech Behav Biomed Mater. 2018 Mar;79:150-157
pubmed: 29304429
Molecules. 2020 Feb 10;25(3):
pubmed: 32050529
PLoS One. 2013;8(2):e56910
pubmed: 23437268
Adv Drug Deliv Rev. 2021 Jun;173:306-330
pubmed: 33798642
Nature. 2011 Jan 20;469(7330):314-22
pubmed: 21248838
Cancer Prev Res (Phila). 2010 Nov;3(11):1361-4
pubmed: 20959519
Biomaterials. 2018 Feb;156:88-106
pubmed: 29190501
Nat Biomed Eng. 2019 Jul;3(7):509-519
pubmed: 31148598
Cytometry A. 2008 Nov;73(11):1019-34
pubmed: 18785636
Nat Biotechnol. 2016 Mar;34(3):312-9
pubmed: 26878319
Front Oncol. 2023 Jun 07;13:1163786
pubmed: 37350937
AAPS PharmSciTech. 2021 Dec 1;23(1):8
pubmed: 34853934
Adv Mater. 2019 Mar;31(10):e1806899
pubmed: 30663123
Trends Biotechnol. 2015 Sep;33(9):504-13
pubmed: 26216543
J Appl Biomater Funct Mater. 2018 Jul;16(3):144-150
pubmed: 29609492
Science. 2012 Nov 16;338(6109):921-6
pubmed: 23161993
Cancer Res. 2011 Feb 1;71(3):790-800
pubmed: 21245098
Micromachines (Basel). 2021 May 09;12(5):
pubmed: 34065040
Angew Chem Int Ed Engl. 2017 Jan 2;56(1):163-168
pubmed: 27897359
Nat Biotechnol. 2014 Aug;32(8):773-85
pubmed: 25093879
Lab Chip. 2016 Nov 29;16(24):4658-4665
pubmed: 27833945
Polymers (Basel). 2017 Aug 30;9(9):
pubmed: 30965706
Genes Dis. 2017 Dec;4(4):185-195
pubmed: 29911158
Tissue Eng Part C Methods. 2014 Jun;20(6):473-84
pubmed: 24188635
J Mol Med (Berl). 2010 Nov;88(11):1095-100
pubmed: 20574808
Biofabrication. 2016 Sep 16;8(3):035020
pubmed: 27634915
Biofabrication. 2019 Dec 31;12(1):015024
pubmed: 31404917
J Biomed Mater Res A. 2017 May;105(5):1457-1468
pubmed: 28187519
Biosensors (Basel). 2022 Aug 05;12(8):
pubmed: 36004998
NPJ Precis Oncol. 2020 Jul 27;4:18
pubmed: 32793806
Int J Mol Sci. 2016 Aug 25;17(9):
pubmed: 27571063
Proc Natl Acad Sci U S A. 2015 Jan 6;112(1):214-9
pubmed: 25524628
Biofabrication. 2015 Nov 02;7(4):045002
pubmed: 26523399
J Pharm Anal. 2021 Oct;11(5):564-579
pubmed: 34765269
Anal Chem. 2020 Jan 7;92(1):892-898
pubmed: 31790197
Nat Rev Cancer. 2005 Aug;5(8):591-602
pubmed: 16056258
Oncogene. 2021 Sep;40(37):5651-5664
pubmed: 34326467
ACS Appl Bio Mater. 2020 Sep 21;3(9):5552-5573
pubmed: 35021789
Exp Dermatol. 2022 Apr;31(4):516-527
pubmed: 34727395
Biofabrication. 2019 Jan 24;11(2):025003
pubmed: 30616234
Biomech Model Mechanobiol. 2019 Aug;18(4):1047-1078
pubmed: 30796640
Front Pharmacol. 2021 Apr 12;12:646836
pubmed: 33912058
Pharmacol Ther. 2018 Apr;184:201-211
pubmed: 29097309
Pharmacol Ther. 2022 Sep;237:108156
pubmed: 35150784
Molecules. 2016 May 25;21(6):
pubmed: 27231892
Clin Med Insights Oncol. 2018 Jul 27;12:1179554918790563
pubmed: 30083066
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Integr Biol (Camb). 2015 Sep;7(9):1068-78
pubmed: 26190039
J Mater Chem B. 2013 Sep 7;1(33):4088-4098
pubmed: 32260961
J Biomech. 2020 Feb 13;100:109568
pubmed: 31902609
Br J Cancer. 1987 Jan;55(1):61-6
pubmed: 3814476
ACS Biomater Sci Eng. 2018 Feb 12;4(2):294-301
pubmed: 29457129
Pharm Dev Technol. 2021 Apr;26(4):490-500
pubmed: 33416013
Biotechnol J. 2019 Dec;14(12):e1900275
pubmed: 31677223
Cell Adh Migr. 2009 Oct-Dec;3(4):334-6
pubmed: 19949308
Life Sci. 2019 Dec 15;239:117009
pubmed: 31669239